<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01727037</url>
  </required_header>
  <id_info>
    <org_study_id>BIABI v1</org_study_id>
    <nct_id>NCT01727037</nct_id>
  </id_info>
  <brief_title>Bronchoscopic Intrabullous Autologous Blood Instillation (BIABI) for Emphysema</brief_title>
  <acronym>BIABI</acronym>
  <official_title>A Feasibility and Safety Study of Bronchoscopic Intrabullous Autologous Blood Instillation for the Treatment of Severe Bullous Emphysema (BIABI Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chelsea and Westminster NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chelsea and Westminster NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with large bullae (large empty air sacs in the lung) may benefit from bullectomy
      (surgery to resect these bullae), however this is a major surgery with significant potential
      morbidity and long hospital stays. Many patients are not well enough to have this surgery, or
      may not wish to have it. A less invasive means of attempting to shrink the size of the bullae
      is to directly inject the patients' own blood into the bullae (we believe that this can lead
      to an inflammatory reaction leading to gradual scarring and volume loss). This can be
      performed bronchoscopically in a 20-30 minute procedure using conscious sedation (avoiding
      general anaesthesia).

      The aim of this study is to assess the effects on lung function, quality of life measures,
      functional measures and CT measured lung volumes of bronchoscopic intrabullous blood
      instillation in patients with bullous emphysema.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2012</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Residual Volume (RV) following treatment</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in TLC 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in RV/TLC ratio 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in FEV1 and FVC 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the intrathoracic gas volume 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in DLCOc 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the SGRQ score 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the mMRC score 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the 6MWD 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in CT measured lung volumes 6 months following treatment</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>6 monhts</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Bullous Emphysema</condition>
  <arm_group>
    <arm_group_label>BIABI arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will undergo intrabullous autologous blood instillation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bronchoscopic intrabullous autologous blood instillation</intervention_name>
    <arm_group_label>BIABI arm</arm_group_label>
    <other_name>BIABI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 35 years

          -  Large bulla on CT scan where bullectomy is contraindicated or is actively avoided.

          -  Hyperinflation - TLC ≥100% predicted, RV ≥150% predicted

          -  Exertional breathlessness (mMRC &gt;0)

          -  Optimum COPD treatment for at least 6 weeks

          -  No COPD exacerbation for at least 6 weeks

          -  Fewer than 3 admissions for infective exacerbations in the preceding 12 months

          -  Written informed consent

        Exclusion Criteria:

          -  Inability to obtain informed consent

          -  Co-morbidities that would render bronchoscopy or sedation unsafe.

          -  Anaemia or other reasons precluding venesection.

          -  Clinically significant bronchiectasis

          -  Arrhythmia or cardiovascular disease that poses a risk during procedure

          -  Lung nodule requiring further investigation or treatment

          -  Subject taking clopidogrel, warfarin, or other anticoagulants and unable to abstain
             for 5 days pre-procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pallav L Shah, MD FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Brompton and Chelsea and Westminster Hospitals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zaid Zoumot, MBBS MRCP MSc</last_name>
    <phone>+442073518029</phone>
    <email>zzoumot@doctors.org.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kings Mill Hospital, Sherwood Forest Hospitals NHS Trust</name>
      <address>
        <city>Mansfield,</city>
        <state>Nottinghamshire,</state>
        <zip>N</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel V Kemp, MBBs MRCP</last_name>
      <phone>+44162362251</phone>
    </contact>
    <investigator>
      <last_name>Samuel V Kemp, MBBS, MRCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Royal Brompton and Harefield NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaid Zoumot, MBBS MRCP MSc</last_name>
      <phone>+442073518029</phone>
      <email>zzoumot@doctors.otg.uk</email>
    </contact>
    <investigator>
      <last_name>Zaid Zoumot, MBBS MRCP MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chelsea and Westminster Hospital NHS Foundation trust</name>
      <address>
        <city>London</city>
        <zip>SW9 0HN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Zaid Zoumot, MBBS MRCP MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2012</study_first_submitted>
  <study_first_submitted_qc>November 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2012</study_first_posted>
  <last_update_submitted>November 19, 2012</last_update_submitted>
  <last_update_submitted_qc>November 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Emphysema</keyword>
  <keyword>Chronic obstructive pulmonary disease</keyword>
  <keyword>COPD</keyword>
  <keyword>Bulla</keyword>
  <keyword>Interventional bronchoscopy</keyword>
  <keyword>Lung volume reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

